{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:55:20Z","timestamp":1785862520104,"version":"3.56.0"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004484","name":"tehran university of medical sciences and health services","doi-asserted-by":"publisher","award":["1400-3-101-56301"],"award-info":[{"award-number":["1400-3-101-56301"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Changes in endothelial function are implicated in the spread of tuberculosis (TB). Studies suggest a role for the vascular endothelial growth factor (VEGF) in TB-related endothelial function changes. However, the findings of studies investigating the VGEF profile in TB are not consistent, and no formal systematic review and meta-analysis exists summarizing these studies.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>We did a meta-analysis of studies assessing VEGF levels in patients with TB. A systematic search on June 25, 2021, was conducted for eligible studies that made VEGF measurements in an unstimulated sample, e.g., a blood fraction (plasma or serum), cerebrospinal fluid (CSF), pleural effusion (PE), or bronchoalveolar lavage fluid, and ascites or pericardial fluid for patients with TB and controls without TB. Also, studies that made simultaneous measurements of VEGF in blood and PE or CSF in the same patients with TB were included. Longitudinal studies that provided these data at baseline or compared pre-post anti-tuberculosis treatment (ATT) levels of VEGF were included. The primary outcome was the standardized mean difference (SMD) of VEGF levels between the comparison groups.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>52 studies were included in the meta-analysis. There were 1787 patients with TB and 3352 control subjects of eight categories: 107 patients with transudative pleural effusion, 228 patients with congestive heart failure (CHF)\/chronic renal failure (CRF), 261 patients with empyema and parapneumonic effusion (PPE), 241 patients with cirrhosis, 694 healthy controls (with latent TB infection or uninfected individuals), 20 patients with inactive tuberculous meningitis (TBM), 123 patients with non-TBM, and 1678 patients with malignancy. The main findings are as follows: (1) serum levels of VEGF are higher in patients with active TB compared with healthy controls without other respiratory diseases, including those with latent TB infection or uninfected individuals; (2) both serum and pleural levels of VEGF are increased in patients with TPE compared with patients with transudative, CHF\/CRF, or cirrhotic pleural effusion; (3) ascitic\/pericardial fluid, serum, and pleural levels of VEGF are decreased in patients with TB compared with patients with malignancy; (4) pleural levels of VEGF are lower in patients with TPE compared with those with empyema and PPE, whereas serum levels of VEGF are not different between these patients; (5) both CSF and serum levels of VEGF are increased in patients with active TBM compared with controls, including patients with inactive TBM or non-TBM subjects; (6) post-ATT levels of VEGF are increased compared with pre-ATT levels of VEGF; and (7) the mean age and male percentage of the TB group explained large and total amount of heterogeneity for the meta-analysis of blood and pleural VEGF levels compared with healthy controls and patients with PPE, respectively, whereas these moderators did not show any significant interaction with the effect size for other analyses.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Discussion<\/jats:title><jats:p>The important limitation of the study is that we could not address the high heterogeneity among studies. There might be unmeasured factors behind this heterogeneity that need to be explored in future research. Meta-analysis findings align with the hypothesis that TB may be associated with abnormal vascular function, and both local and systemic levels of VEGF can be used to trace this abnormality.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0268543","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:37:43Z","timestamp":1653500263000},"page":"e0268543","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0945-8443","authenticated-orcid":true,"given":"Amene","family":"Saghazadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3836-1827","authenticated-orcid":true,"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"issue":"3","key":"pone.0268543.ref001","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1440-1843.2003.00471.x","article-title":"Elevated levels of circulating adhesion molecules in patients with active pulmonary tuberculosis","volume":"8","author":"H Mukae","year":"2003","journal-title":"Respirology (Carlton, Vic)"},{"issue":"6","key":"pone.0268543.ref002","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"N Ferrara","year":"2003","journal-title":"Nature medicine"},{"issue":"7","key":"pone.0268543.ref003","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS medicine"},{"key":"pone.0268543.ref004","article-title":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"GA Wells","year":"2000","journal-title":"Oxford"},{"issue":"5","key":"pone.0268543.ref005","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000050557","article-title":"Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis","volume":"68","author":"Y Abe","year":"2001","journal-title":"Respiration; international review of thoracic diseases"},{"issue":"515","key":"pone.0268543.ref006","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw8287","article-title":"A rapid triage test for active pulmonary tuberculosis in adult patients with persistent cough","volume":"11","author":"R Ahmad","year":"2019","journal-title":"Science translational medicine"},{"issue":"6","key":"pone.0268543.ref007","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1378\/chest.125.6.2156","article-title":"Vascular endothelial growth factor levels in active pulmonary tuberculosis","volume":"125","author":"F Alatas","year":"2004","journal-title":"Chest"},{"issue":"11","key":"pone.0268543.ref008","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.6061\/clinics\/2012(11)06","article-title":"Pleural tuberculosis: is radiological evidence of pulmonary-associated disease related to the exacerbation of the inflammatory response?","volume":"67","author":"L Antonangelo","year":"2012","journal-title":"Clinics (Sao Paulo, Brazil)"},{"issue":"1","key":"pone.0268543.ref009","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/njcp.njcp_370_16","article-title":"Vascular endothelial growth factor in pleural effusions and correlation with radiologic and biochemical parameters","volume":"21","author":"N Bayram","year":"2018","journal-title":"Nigerian journal of clinical practice"},{"issue":"1","key":"pone.0268543.ref010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5958\/0976-5506.2019.00039.1","article-title":"Serum VEGF and TNF-\u03b1 correlate bacterial burden in pulmonary tuberculosis","volume":"10","author":"H Bhat","year":"2019","journal-title":"Indian Journal of Public Health Research and Development"},{"key":"pone.0268543.ref011","article-title":"The Significance of Detecting Vascular Endothelial Growth Factor in Differentiating Tuberculosis Pleural Effusion from Malignant Pleural Effusions.","volume":"03","author":"Y-f Chen","year":"2003","journal-title":"The Practical Journal of Cancer"},{"issue":"5","key":"pone.0268543.ref012","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1183\/09031936.00126306","article-title":"Discrimination of exudative pleural effusions based on multiple biological parameters","volume":"30","author":"ZD Daniil","year":"2007","journal-title":"The European respiratory journal"},{"issue":"2","key":"pone.0268543.ref013","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cyto.2009.05.016","article-title":"Differential cytokine\/chemokines and KL-6 profiles in patients with different forms of tuberculosis","volume":"47","author":"JF Djoba Siawaya","year":"2009","journal-title":"Cytokine"},{"issue":"11","key":"pone.0268543.ref014","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.3748\/wjg.v9.i11.2596","article-title":"Role of VEGF and CD44v6 in differentiating benign from malignant ascites","volume":"9","author":"WG Dong","year":"2003","journal-title":"World journal of gastroenterology"},{"issue":"3","key":"pone.0268543.ref015","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ejcdt.2014.02.008","article-title":"Role of vascular endothelial growth factor (VEGF) in diagnosis of pleural effusion of different origins","volume":"63","author":"M Fathy","year":"2014","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"issue":"3","key":"pone.0268543.ref016","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1515\/labmed-2014-0006","article-title":"Mediators in pleural effusions of different origin: a two-step diagnostic study","volume":"38","author":"S Fricke","year":"2014","journal-title":"Laboratoriumsmedizin-Journal of Laboratory Medicine"},{"issue":"1","key":"pone.0268543.ref017","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1440-1843.2003.00529.x","article-title":"Vasoactive mediators (VEGF and TNF-alpha) in patients with malignant and tuberculous pleural effusions","volume":"9","author":"EA Hamed","year":"2004","journal-title":"Respirology (Carlton, Vic)"},{"issue":"2","key":"pone.0268543.ref018","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jinf.2007.11.004","article-title":"Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis","volume":"56","author":"N Husain","year":"2008","journal-title":"The Journal of infection"},{"issue":"2","key":"pone.0268543.ref019","first-page":"171","article-title":"Clinical Significance of Vascular Endothelial Growth Factor in Patients with Lung Cancer and Tuberculous Pleurisy","volume":"50","author":"BK Im","year":"2016","journal-title":"Tuberculosis and Respiratory Diseases"},{"issue":"5\u20136","key":"pone.0268543.ref020","first-page":"258","article-title":"Evaluation of vascular endothelial growth factor (VEGF) in neoplastic and tuberculosis effusions\u2014preliminary results","volume":"70","author":"R Jankowska","year":"2002","journal-title":"Pneumonologia i alergologia polska"},{"issue":"2","key":"pone.0268543.ref021","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.rmed.2003.09.002","article-title":"Vascular endothelial growth factor correlates with matrix metalloproteinase-9 in the pleural effusion","volume":"98","author":"HY Jin","year":"2004","journal-title":"Respiratory medicine"},{"issue":"5","key":"pone.0268543.ref022","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.129.5.1259","article-title":"Angiopoietin-2 levels are elevated in exudatative pleural effusions","volume":"129","author":"I Kalomenidis","year":"2006","journal-title":"Chest"},{"issue":"7","key":"pone.0268543.ref023","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1579-2129(06)60244-9","article-title":"Vascular endothelial growth factor in benign and malignant pleural effusions","volume":"41","author":"A Kaya","year":"2005","journal-title":"Archivos de bronconeumologia"},{"issue":"1","key":"pone.0268543.ref024","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejcdt.2016.12.006","article-title":"Vascular endothelial growth factor in diagnosis of pleural effusion","volume":"66","author":"NH Khalil","year":"2017","journal-title":"Egyptian Journal of Chest Diseases and Tuberculosis"},{"issue":"2","key":"pone.0268543.ref025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1620\/tjem.242.137","article-title":"Diagnostic Significance of Measuring Vascular Endothelial Growth Factor for the Differentiation between Malignant and Tuberculous Pleural Effusion","volume":"242","author":"HR Kim","year":"2017","journal-title":"The Tohoku journal of experimental medicine"},{"issue":"1","key":"pone.0268543.ref026","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1378\/chest.128.1.468","article-title":"Vascular endothelial growth factor levels in pleural fluid and serum of patients with tuberculous pleural effusions [6] (multiple letters)","volume":"128","author":"TS Kiropoulos","year":"2005","journal-title":"Chest"},{"issue":"9","key":"pone.0268543.ref027","first-page":"1683","article-title":"Expressions of miR-29a, TNF-A and Vascular Endothelial Growth Factor in Peripheral Blood of Pulmonary Tuberculosis Patients and Their Clinical Significance","volume":"49","author":"ZY Li","year":"2020","journal-title":"Iranian journal of public health"},{"issue":"3","key":"pone.0268543.ref028","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3346\/jkms.2000.15.3.279","article-title":"Vascular endothelial growth factor in malignant and tuberculous pleural effusions","volume":"15","author":"SC Lim","year":"2000","journal-title":"Journal of Korean medical science"},{"issue":"1","key":"pone.0268543.ref029","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000313465","article-title":"Preliminary investigation of the clinical value of vascular endothelial growth factor and hypoxia-inducible factor-1alpha in pericardial fluid in diagnosing malignant and tuberculous pericardial effusion","volume":"116","author":"J Liu","year":"2010","journal-title":"Cardiology"},{"issue":"1\u20132","key":"pone.0268543.ref030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0022-510X(01)00515-9","article-title":"Expression of vascular endothelial growth factor in tuberculous meningitis","volume":"186","author":"W Matsuyama","year":"2001","journal-title":"Journal of the neurological sciences"},{"issue":"4","key":"pone.0268543.ref031","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jinf.2012.11.005","article-title":"Plasma cytokines and chemokines differentiate between active disease and non-active tuberculosis infection","volume":"66","author":"A Mihret","year":"2013","journal-title":"The Journal of infection"},{"issue":"2","key":"pone.0268543.ref032","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3109\/00207454.2012.743127","article-title":"Vascular endothelial growth factor in tuberculous meningitis","volume":"123","author":"UK Misra","year":"2013","journal-title":"The International journal of neuroscience"},{"issue":"10","key":"pone.0268543.ref033","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1053\/rmed.2002.1364","article-title":"Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions","volume":"96","author":"H Momi","year":"2002","journal-title":"Respiratory medicine"},{"issue":"1","key":"pone.0268543.ref034","first-page":"2978","article-title":"Clinical Implications for Vascular Endothelial Growth Factor Levels among Egyptians with Pulmonary Tuberculosis","volume":"10","author":"M Omar","year":"2013","journal-title":"Life Science Journal-Acta Zhengzhou University Overseas Edition"},{"key":"pone.0268543.ref035","doi-asserted-by":"crossref","first-page":"33162","DOI":"10.1038\/srep33162","article-title":"Mycobacterium tuberculosis exploits the formation of new blood vessels for its dissemination","volume":"6","author":"H Polena","year":"2016","journal-title":"Scientific reports"},{"key":"pone.0268543.ref036","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2172-13-45","article-title":"Immune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis","volume":"13","author":"D Qama","year":"2012","journal-title":"BMC immunology"},{"issue":"4","key":"pone.0268543.ref037","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4149\/neo_2012_056","article-title":"Vascular endothelial growth factor and soluble intercellular adhesion molecule-1 in lung adenocarcinoma with malignant pleural effusion: correlations with patient survival and pleural effusion control","volume":"59","author":"Q Qian","year":"2012","journal-title":"Neoplasma"},{"issue":"6","key":"pone.0268543.ref038","first-page":"806","article-title":"Diagnostic value of vascular endothelial growth factor and adenosine deaminase detection in differentiating tuberculous meningitis from viral meningitis","volume":"30","author":"B Qiu","year":"2009","journal-title":"Medical Journal of Wuhan University"},{"key":"pone.0268543.ref039","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fmicb.2018.00275","article-title":"Cytokine Biomarkers Associated with Human Extra-Pulmonary Tuberculosis Clinical Strains and Symptoms","volume":"9","author":"P Ranaivomanana","year":"2018","journal-title":"Frontiers in microbiology"},{"issue":"3","key":"pone.0268543.ref040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00408-004-2533-0","article-title":"Angiogenic factors and angiogenesis inhibitors in exudative pleural effusions","volume":"183","author":"E Ruiz","year":"2005","journal-title":"Lung"},{"issue":"4","key":"pone.0268543.ref041","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1183\/09031936.05.00037004","article-title":"Vascular endothelial growth factor in pleural effusions of different origin","volume":"25","author":"U Sack","year":"2005","journal-title":"The European respiratory journal"},{"key":"pone.0268543.ref042","article-title":"Adjunct N-Acetylcysteine Treatment in Hospitalized Patients With HIV-Associated Tuberculosis Dampens the Oxidative Stress in Peripheral Blood: Results From the RIPENACTB Study Trial","volume":"11","author":"IP Safe","year":"2021","journal-title":"Frontiers in immunology"},{"issue":"2","key":"pone.0268543.ref043","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00408-018-0090-1","article-title":"Diagnostic Value of Vascular Endothelial Growth Factor, Transforming Growth Factor-beta, Interleukin-8, and the Ratio of Lactate Dehydrogenase to Adenosine Deaminase in Pleural Effusion","volume":"196","author":"T Saraya","year":"2018","journal-title":"Lung"},{"issue":"9","key":"pone.0268543.ref044","first-page":"1153","article-title":"Pleural fluid cytokines correlate with tissue inflammatory expression in tuberculosis","volume":"14","author":"M Seiscento","year":"2010","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"issue":"4","key":"pone.0268543.ref045","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5301\/tj.5000320","article-title":"Clinical implications of serum hypoxia inducible factor-1 alpha and vascular endothelial growth factor in lung cancer.","volume":"101","author":"H Shen","year":"2015","journal-title":"Tumori"},{"issue":"3","key":"pone.0268543.ref046","first-page":"209","article-title":"Role of cytokines in the assessment of clinical outcome and neuroimaging findings in patients with tuberculous meningitis","volume":"22","author":"M Tai","year":"2017","journal-title":"Neurology Asia"},{"issue":"3","key":"pone.0268543.ref047","first-page":"40","article-title":"Vascular Endothelial Growth Factor for Differential Diagonsis of Nonmalignant Pleural Effusions","volume":"5","author":"D Tas","year":"2009","journal-title":"Nobel Medicus"},{"issue":"6","key":"pone.0268543.ref048","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00408-016-9945-5","article-title":"Profile of Metalloproteinases and Their Association with Inflammatory Markers in Pleural Effusions","volume":"194","author":"LR Teixeira","year":"2016","journal-title":"Lung"},{"issue":"1\u20132","key":"pone.0268543.ref049","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2152\/jmi.54.146","article-title":"Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions","volume":"54","author":"H Tomimoto","year":"2007","journal-title":"The journal of medical investigation: JMI"},{"issue":"7","key":"pone.0268543.ref050","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/01.inf.0000131634.57368.45","article-title":"Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis","volume":"23","author":"M van der Flier","year":"2004","journal-title":"The Pediatric infectious disease journal"},{"issue":"2","key":"pone.0268543.ref051","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/cid\/ciu781","article-title":"Host immune response to tuberculous meningitis","volume":"60","author":"DH Visser","year":"2015","journal-title":"Clinical infectious diseases: an official publication of the Infectious Diseases Society of America"},{"issue":"1","key":"pone.0268543.ref052","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12967-018-1572-x","article-title":"Screening and identification of a six-cytokine biosignature for detecting TB infection and discriminating active from latent TB","volume":"16","author":"S Wang","year":"2018","journal-title":"Journal of translational medicine"},{"issue":"5","key":"pone.0268543.ref053","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s11596-007-0504-4","article-title":"Clinical value of vascular endothelial growth factor combined with interferon-gamma in diagnosing malignant pleural effusion and tuberculous pleural effusion","volume":"27","author":"K Xue","year":"2007","journal-title":"Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban"},{"issue":"3","key":"pone.0268543.ref054","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1007\/s13277-015-4198-0","article-title":"The clinical significance of vascular endothelial growth factor in malignant ascites","volume":"37","author":"N Zhan","year":"2016","journal-title":"Tumor Biology"},{"issue":"19","key":"pone.0268543.ref055","doi-asserted-by":"crossref","first-page":"8435","DOI":"10.7314\/APJCP.2014.15.19.8435","article-title":"Prognostic values of VEGF and endostatin with malignant pleural effusions in patients with lung cancer","volume":"15","author":"Y Zhang","year":"2014","journal-title":"Asian Pacific journal of cancer prevention: APJCP"},{"issue":"3","key":"pone.0268543.ref056","first-page":"381","article-title":"Diagnostic value of vascular endothelial growth factor and endostatin in malignant pleural effusions","volume":"13","author":"WB Zhou","year":"2009","journal-title":"The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease"},{"key":"pone.0268543.ref057","first-page":"563","volume-title":"Macrophages in tuberculosis: friend or foe","author":"E Guirado","year":"2013"},{"issue":"3","key":"pone.0268543.ref058","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.tube.2013.02.002","article-title":"Modulation of angiogenic factor VEGF by DNA-hsp65 vaccination in a murine CNS tuberculosis model","volume":"93","author":"FCR Zucchi","year":"2013","journal-title":"Tuberculosis"},{"issue":"3\u20134","key":"pone.0268543.ref059","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.pathophys.2019.11.004","article-title":"Dysregulation of VEGF-dependent angiogenesis in cavernous lung tuberculosis","volume":"26","author":"EP Golubinskaya","year":"2019","journal-title":"Pathophysiology: the official journal of the International Society for Pathophysiology"},{"issue":"3","key":"pone.0268543.ref060","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1164\/ajrccm.162.3.9911010","article-title":"Increased serum level of vascular endothelial growth factor in pulmonary tuberculosis","volume":"162","author":"W Matsuyama","year":"2000","journal-title":"American journal of respiratory and critical care medicine"},{"issue":"5","key":"pone.0268543.ref061","doi-asserted-by":"crossref","first-page":"e0176660","DOI":"10.1371\/journal.pone.0176660","article-title":"A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis","volume":"12","author":"S Ferrian","year":"2017","journal-title":"PloS one"},{"issue":"1","key":"pone.0268543.ref062","doi-asserted-by":"crossref","first-page":"e0146318","DOI":"10.1371\/journal.pone.0146318","article-title":"Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis","volume":"11","author":"NP Kumar","year":"2016","journal-title":"PloS one"},{"key":"pone.0268543.ref063","doi-asserted-by":"crossref","first-page":"417124","DOI":"10.1155\/2015\/417124","article-title":"VEGF correlates with inflammation and fibrosis in tuberculous pleural effusion","volume":"2015","author":"MY Bien","year":"2015","journal-title":"TheScientificWorldJournal"},{"issue":"6","key":"pone.0268543.ref064","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1073\/pnas.1424563112","article-title":"Anti-vascular endothelial growth factor treatment normalizes tuberculosis granuloma vasculature and improves small molecule delivery","volume":"112","author":"M Datta","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"pone.0268543.ref065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5301\/ejo.5000528","article-title":"Optic nerve head tubercular granuloma successfully treated with anti-VEGF intravitreal injections in addition to systemic therapy","volume":"25","author":"A Invernizzi","year":"2015","journal-title":"European journal of ophthalmology"},{"key":"pone.0268543.ref066","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2147\/IMCRJ.S128885","article-title":"Anti-VEGF therapy for central retinal vein occlusion caused by tuberculosis-associated uveitis: a case report","volume":"10","author":"M Taguchi","year":"2017","journal-title":"International medical case reports journal"},{"issue":"2","key":"pone.0268543.ref067","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijcard.2007.07.010","article-title":"Inflammation, endothelial dysfunction and angiogenesis markers in chronic heart failure patients","volume":"130","author":"V Vila","year":"2008","journal-title":"International journal of cardiology"},{"issue":"3","key":"pone.0268543.ref068","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jacc.2003.08.042","article-title":"Plasma angiopoietin-1, angiopoietin-2, and angiopoietin receptor tie-2 levels in congestive heart failure","volume":"43","author":"AY Chong","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"12","key":"pone.0268543.ref069","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/sj.bjc.6603176","article-title":"Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature","volume":"94","author":"G Des Guetz","year":"2006","journal-title":"British journal of cancer"},{"issue":"5","key":"pone.0268543.ref070","first-page":"577","article-title":"VEGF and survival of patients with lung cancer: a systematic literature review and meta-analysis","volume":"19","author":"P Delmotte","year":"2002","journal-title":"Revue des maladies respiratoires"},{"issue":"5","key":"pone.0268543.ref071","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1007\/s13277-013-0886-9","article-title":"Prognostic significance of VEGF immunohistochemical expression in oral cancer: A meta-analysis of the literature","volume":"34","author":"S-F Zhao","year":"2013","journal-title":"Tumor Biology"},{"issue":"7","key":"pone.0268543.ref072","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/sj.bjc.6603923","article-title":"Where is VEGF in the body? A meta-analysis of VEGF distribution in cancer","volume":"97","author":"C Kut","year":"2007","journal-title":"British journal of cancer"},{"issue":"6","key":"pone.0268543.ref073","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00280-013-2298-3","article-title":"The VEGF pathway in lung cancer","volume":"72","author":"M Alevizakos","year":"2013","journal-title":"Cancer chemotherapy and pharmacology"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T22:16:26Z","timestamp":1727302586000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268543"}},"subtitle":[],"editor":[{"given":"Martin E.","family":"Rottenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":73,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268543","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}